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doi:10.1016/j.ejvs.2009.05.015Abstract Objectives: This study aims to evaluate the feasibility of external polyester
scaffolding in infrainguinal bypass grafting when available vein material is suboptimal due to
varicosity or dilatation. Primary objectives were short-term primary patency, assisted primary
patency and secondary patency. Secondary objectives were to assess the rate of graft
stenoses, infections and other adverse effects related to the use of external scaffolding.
Materials and methods: A total of 50 consecutive patients were included in this prospective,
multicentre, feasibility study from six centres. The indication for infrainguinal bypass was crit-
ical limb ischaemia (64%), severe claudication (34%) or popliteal aneurysm (2%). Indications for
the use of the external scaffolding were varicosity of the vein graft, ectatic vein graft or the
use of spliced vein grafts with segments of widely differing diameters. Duplex scanning of the
graft was done perioperatively and at follow-up visits at 1, 3, 6 and 12 months after operation.
Results: Primary patency, assisted primary patency and secondary patency at 6 months were
82.3% (SE 6.2%), 88.6% (SE 4.8%) and 92.1% (SE 4.4%), respectively. Six graft stenoses were
detected in duplex surveillance. There were no infections related to polyester mesh.
Conclusions: External scaffolding of infrainguinal vein grafts may be a promising innovation.
Early results from this multicentre study show that polyester mesh is safe and feasible adjunct
to peripheral revascularization enabling the use of otherwise non-optimal vein grafts with
acceptable short-term patency.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved., Department of Vascular
l Hospital, P.O. Box 340,
4271009.
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ty for Vascular Surgery. PublisheAutologous vein is considered to be superior to prosthetic
grafts as bypass material for infrainguinal reconstructions
in terms of long-term patency and resistance to infections.
Klinkert et al.1 reviewed the literature and concluded that
saphenous vein is the graft of choice for infra- and supra-
popliteal bypasses if only available and of acceptabled by Elsevier Ltd. All rights reserved.
Table 1 Characteristics of patients undergoing vein
bypass with external polyester scaffolding.
Characteristic nZ 50 %
Age, median (range) 72 (39e93)
Body mass index (bmi),
median (range)
27.0 (20.0e39.0)
Male gender 34 68
Coronary artery disease 24 48
Diabetes 21 42
Renal insufficiency
(creatinine >120 mmol/l)
9 18
Hypertension 40 80
Hyperlipidemia 27 54
Current smoking 13 26
Indicationa
Claudication 17 34
Ischaemic rest pain 6 12
Ulcer or gangrene 26 52
Popliteal aneurysm 1 2
Preoperative medication
Aspirin 29 58
Clopidogrel 7 14
Warfarin 10 20
a CLI as indication: Helsinki 17/20; Mainz 5/13; Frankfurt
8/10; Mu¨hldorf 1/3; Essen 0/1; Wittlich 0/1.
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have also been shown to be superior compared to
prosthetic grafts especially for infrapopliteal revascular-
izations.2e4 Unfortunately, autologous veins are occasion-
ally of non-optimal quality due to small-calibre, varicosities
or post-phlebitic changes. Varicosity is usually a contrain-
dication to autologous vein bypass because of increased
formation of intimal hyperplasia, the risk of aneurysm
formation and even grafts rupture. Arm veins are often thin
walled and their diameter is large especially at proximal
portions. Therefore, they can be liable to long-term
dilatation.5
External polyester mesh tube provides external support
for autologous vein grafts of compromised quality and limits
postoperative dilatation of the vein graft in the dramati-
cally different haemodynamics of the arterial system. The
use of external support has been proposed to allow the use
of non-optimal quality veins otherwise unacceptable for
bypass grafting. External mesh is supposed to stabilise
the vein, and thus minimise the arterial stress with the
objective of reducing the rate of stenosis and therefore
improve patency. Numerous preclinical animal studies
employing external support of autologous suboptimal-
quality vein bypasses have shown a less-pronounced neo-
intima formation as the underlying cause for significantly
improved long-term patency rates compared to unsup-
ported grafts.6e9 Moreover, several small clinical series
have shown that both polytetrafluoroethylene (PTFE) and
polyester prosthetic reinforcement of varicose vein grafts
can be used with acceptable results.10e17
The aim of this study was to evaluate the feasibility and
short-term outcome of external polyester mesh tube in
infrainguinal bypass procedures when available vein mate-
rial is of non-optimal quality. The primary objective was to
assess short-term primary, assisted primary and secondary
patencies. Secondary objectives were to evaluate the
severity of intimal thickening of grafts during follow-up,
infection rate and other complications and practical prob-
lems related to the use of external scaffolding.
Material and Methods
This study was a prospective, multicentre, observational
pilot study. In the Helsinki University Central Hospital, 20
patients were included from May 2005 to March 2008. At the
same time, in five German centres a similar study was
started, which included 30 patients. The data from all six
centres with a total of 50 patients were combined.
Participating centres were: Helsinki University Central
Hospital, Finland (20 patients); Johannes Gutenberg
University Hospital Mainz, Germany (13 patients); J.W.
Goethe University Hospital, Frankfurt, Germany (12
patients); Municipal Hospital Muehldorf, Germany (three
patients); Verbundkrankenhaus Bernkastel/Wittlich, Wit-
tlich, Germany (one patient) and Kath. Kliniken Essen-Nord,
Essen, Germany (one patient).
Informed consent
Informed consent was obtained from all patients before
they entered the study. The nature, purpose and risks ofthe study were explained, and the patients were provided
with a copy of the patient information sheet. The study
protocol was approved by ethics committee and the Insti-
tutional Review Board of Helsinki University Central
Hospital.
Patient inclusion and exclusion criteria
Patients included had to be suitable for bypass operation
with overall health status permitting vascular surgery and
anaesthesia with adjunctive medications. Indication for
surgery was critical limb ischaemia with rest pain or
a non-infected ulcer or severe claudication resistant to
conservative treatment. One patient was operated for
a popliteal aneurysm (Table 1). In all patients, the quality
of vein material was suboptimal due to varicosities or
ectatic dilatation. There were small differences between
participating centres concerning vein-quality criteria. In
Germany only patients with varicotic vein grafts were
included whereas in Finland also patients with ectatic
(diameter >8 mm) arm veins and patients with spliced vein
grafts with at least one ectatic segment were included.
Exclusion criteria were grossly infected gangrene in the
affected limb and life expectancy less than 1 year which
would have excluded follow-up visits. Patients were also
excluded if they were unable to understand the full
meaning of the informed consent.
Description of the polyester mesh product
The polyester mesh tube (ProVena, B. Braun Aesculap,
Germany) is manufactured from multifilament polyester
458 E. Arvela et al.yarn (polyethylene terephthalate) and supplied in various
diameters and lengths. ProVena is an open porous pros-
thesis with honeycomb-like structure for intra-operative
external scaffolding of autologous veins. The desired length
of the tube network is drawn over the autologous vein and
it adapts to the vein configuration irregularities.
Clinical evaluation
Clinical evaluation including medical history, inspection of
the limb status and vascular laboratory assessment (ankle-
brachial indices (ABIs) and toe pressure measurements) was
performed in all patients before bypass operation. The
suitability of arterial anatomy for bypass was evaluated by
magnetic resonance angiography (MRA) or conventional
digital subtraction angiography (DSA). The vein graft was
preoperatively evaluated by duplex scanning (i.e., vein
mapping).
Procedure
Vascular surgeons experienced in the diagnosis and treat-
ment of lower limb ischaemia performed the operations.
Conforming to hospital routine, prophylactic antibiotics
were administered to all patients as if they were receiving
a prosthetic bypass. Infrainguinal bypass with autologous
vein was performed according to the preference of the
operating surgeon. The operating surgeon decided whether
the vein graft was to be used in reversed or non-reversed
position. If spliced vein graft was used, reversed or non-
reversed vein segments were employed to minimise size
mismatch of vein-to-vein anastomoses and artery-to-vein
anastomoses. The vein-to-vein anastomoses were sutured
with 7/0 interrupted sutures. Prior to suturing the arteriale
vein anastomoses, an appropriate length of polyester mesh
tube was drawn over the vein graft with a specially
designed instrument. Generally, fibrin glue was used to fix
the mesh to the outer layer of vein graft to facilitate
anastomosis suturing if the mesh tube was extended to
cover one or both anastomoses (Fig. 1A and B). At the end
of the procedure a transit time measurement was used to
ensure adequate graft flow, and intra-operative duplex
scanning was performed to exclude graft segments of
inappropriate quality and technical defects in anasto-
moses. If the duplex scanning was not performed intra-
operatively, it was performed postoperatively beforeFigure 1 (A) Proximal anastomosis and vein-to-vein anastomosis a
vein graft (B) Distal anastomosis of a femoral-to anterior tibial artdischarge. Completion angiography was not routinely
performed.
Additional vascular procedures
All additional vascular procedures including graft revisions
and angioplasties of the bypassed extremity during follow-
up were registered. Wound revisions, skin grafts and minor
amputations were not considered to be additional proce-
dures in this study.
Follow-up
There were some differences concerning the surveillance
programmes between participating centres. In Helsinki,
follow-up visits were at 1(e2), 6 and 12 months after
operation. All five German centres had follow-up visits at 1,
3 and 6 months postoperatively. At each follow-up visit the
evaluation protocol was the same, including inspection of
the limb status, measurement of ankle-brachial indices
(ABIs) and toe pressures and duplex scanning of the entire
graft. The velocity ratio (Vr) over 3.0 or the peak systolic
velocity (PSV) over 300 cm s1 was used as threshold value
for significant graft stenosis.
Data collection and statistical analyses
Clinical data was collected at patient enrolment, at the time
of the procedure, at discharge and at planned follow-up
visits. Data were collected using patient record forms.
KaplaneMeier method was used to calculate primary, assis-
ted primary and secondary patencies. SPSS for Windows,
version 16.0 (SPSS Inc., Chicago, IL, USA) was used for
statistical analyses.
Results
Median age of the study population was 72 years. Two-thirds
of patients (68%)weremale. Almost half (48%) of thepatients
had coronary artery disease. The incidence of diabetes was
42%. The study population had also a number of other
concurrent diseases (Table 1). One patient had thrombo-
philia (antiphospholipid antibodies), which had previously
been diagnosed after deep venous thrombosis. Thirty-four
(68%) vein grafts consisted of a one-piece saphenous vein,
the restwere spliced vein grafts (Table 2). The outflowarteryre completed and polyester mesh is drawn over the spliced arm
ery bypass is completed.
Table 2 Operative details of bypass surgery with exter-
nally supported vein grafts.
n %
Inflow artery
Common femoral artery 39 78
Superficial femoral artery 5 10
Deep femoral artery 1 2
Proximal popliteal artery 3 6
Distal popliteal artery 1 2
Graft (limb of aortofemoral
graft)
1 2
Outflow artery
Proximal popliteal artery 9 18
Distal popliteal artery 17 34
Anterior tibial artery 8 16
Posterior tibial artery 6 12
Peroneal artery 9 18
Pedal artery 1 2
Vein graft material
GSV (single piece)
Spliced vein (two pieces)
34 68
GSVþGSV 5 10
GSVþ SSV 3 6
GSVþ ceph 2 4
GSVþ bas 1 2
Cephþ bas 2 4
Spliced vein (three pieces)
GSVþGSVþ SSV 1 2
GSVþGSVþ ceph 1 2
Cephþ cephþ bas 1 2
Vein graft configuration
Reversed 21 42
Non-reversed 25 50
Both (spliced vein grafts) 4 8
Polyester mesh
Length (cm), median (range) 40 (10e70)
Diameter (mm), median (range) 6 (4e8)
GSVZ great saphenous vein; SSVZ short saphenous vein;
cephZ cephalic vein; basZ basilic vein.
Figure 2 Cumulative primary patency, assisted primary
patency and secondary patency. Numbers indicate grafts at
risk. Standard error (SE) was <10% throughout the time
interval.
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infrapopliteal outflow artery was the peroneal artery (18%)
(Table 2). The indication for the use of external scaffolding
was varicosity (60%) or ectatic dilatation of the graft or at
least one of the vein segments in spliced vein graft (40%).
Primary, assisted primary and secondary patencies with
standard errors (SEs) at 6 months were 82.3% (SE 6.2%),
88.6% (SE 4.8%) and 92.1% (SE 4.4%), respectively
(Fig. 2). A total of six graft stenoses were detected under
duplex surveillance. Two of them were <50% stenoses
(Vr< 2.0e3.0) outside the scaffolded part of the graft
detected 3 months after operation. These stenoses did not
require balloon angioplasty. One stenosis exceeding 50%
(Vr 3.0e4.0) in the middle of the graft and another over 50%
stenosis in the proximal part of the graft required balloon
angioplasty. There was also one 75% (Vr> 4.0) mid-graft
stenosis, which was treated endovascularly. One high-grade
stenosis (Vr> 7.0) above the scaffolded segment wastreated with interposition. The only immediate failure
occurred on the third postoperative day and was treated by
thrombectomy and patch angioplasty of distal anastomosis.
There were four graft occlusions at 2, 4, 5 and 9 months,
postoperatively, all but one without limb loss. The graft
occlusion at 5 months postoperatively led to below-knee
amputation 1 month later. This patient received the bypass
for critical limb ischaemia. One patient with crural ulcers
and former aorto-bi-femoral prosthesis was maintained on
long-term antibiotics. One patient had postoperative
cellulitis in the operated limb but negative ultrasonography
and scintigraphy ruled out the infection of the polyester
mesh. Thus, there were no severe infections related to
polyester mesh tube.
In a subgroup of patients with critical limb ischaemia,
survival and limb salvage at 1 year were 88.2% (SE 6.4%)
and 90.0% (SE 6.7%), respectively. In addition to the
amputation due to graft occlusion and persisting ischaemia,
another major amputation was performed due to persistent
gangrene despite of patent bypass 6 months after
revascularization.
Five patients were lost to follow-up, one after discharge
from hospital and four others at 1, 5, 12 and 13 months
postoperatively. The median follow-up time was 7 months
(range: 0e36 months).
Completion angiographies, though not used routinely,
confirmed uniform vessel configurations even in vein grafts
that were originally heavily varicotic (Fig. 3AeC).
Discussion
The idea of scaffolding the vein grafts is not new. External
reinforcement of normal vein graft with a polyester graft
was first described in 1963.10 Melliere et al.11 reported on
a small series of patients with critical limb ischaemia
whereby dilated segments of greater saphenous veins were
wrapped in short segments of PTFE prosthesis or hand-
made polyester mesh. Neufang et al.14 reported over 80%
secondary patency rates at 1 year for PTFE-reinforced
varicotic vein grafts in infrainguinal bypass surgery.
Figure 3 (AeC) Postoperative angiography of originally heavily varicotic greater saphenous vein graft with diameter difference
from 4 to 12 mm after implantation of polyester mesh tube of 5 mm diameter.
460 E. Arvela et al.Recently Mellie`re et al.15 concluded that patency rates
using varicotic vein grafts with prosthetic reinforcement
are higher than those achieved using prosthetic grafts. They
also found that reinforced vein graft zones did not develop
stenosis and unreinforced zones developed little or no
dilatation.
Although it has been demonstrated in several animal
studies that external support reduces intimal hyperplasia,
the ideal scaffolding material has yet not been identified.
According to a recent study,18 external stenting with
macro-porous polyester mesh reduced neointimal hyper-
plasia more effectively than PTFE and other commercially
available stents possibly due to better circumferential
compliance. In our series, the same kind of macro-porous
material was used.
In infrainguinal vein bypasses the incidence of focal
stenoses due to intimal hyperplasia is 20e35% within 1e2
years after operation.19e23 Arm vein grafts are especially
prone to development of stenosis and aneurysm.5 The
incidence of vein graft abnormalities after arm vein bypass
has been reported to be as high as 55%.5 In our series, 12%
of these non-optimal vein grafts developed stenosis within
6 months. There were no aneurysms of vein grafts.
In this study, two-thirds of patients were operated due
to critical limb ischaemia. Patency rates in this series are
comparable to results of previous studies by others where
prosthetic reinforcement of the vein grafts was used.10e17
Furthermore, secondary patency at 1 year resembled thosereported in large series of good-quality infrainguinal venous
bypasses for critical limb ischaemia without graft rein-
forcement.24 Vein graft material used in this series was
non-optimal, and therefore our results can be considered to
be acceptable compared to results obtained from other
series.25 Primary patency at 6 months in our series was
82.3%, but assisted primary and secondary patencies were
significantly better, which emphasises the importance of
vein graft surveillance. Duplex surveillance seems to be
especially important in arm vein grafts. Armstrong et al.5
found that duplex surveillance resulted in a 49% interven-
tion rate after arm vein bypass.
Apart from the use on varicotic grafts, the external
scaffolding is probably most beneficial in arm veins, in
heavily dilated vein grafts and in spliced vein grafts with
segments of different sizes. One advantage of polyester
mesh is that it secures side-branch clips even during graft
tunnelling. Furthermore, when polyester mesh is correctly
in place, it aids in avoiding twisting of the graft during
tunnelling. In cases were a thin-walled arm vein is sutured
to a long arteriotomy after femoral endarterectomy, the
polyester mesh provides the required support. On the other
hand, the use of external scaffolding necessitates more
equipment and makes the procedure more complex and
time consuming. Disruption of the valves of totally covered
non-reversed vein grafts is more difficult as valve pockets
are no longer visible. However, this problem can be handled
by initial covering of only a short segment of the proximal
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proximal anastomosis and valve lysis. Especially when
the graft diameter is normalised in post-phlebitic veins or
the cephalic vein including antecubital portion, severe
thickening of the vein wall and intraluminal pathology
should be ruled out by intra-operative evaluation to avoid
stenosis of the graft. The polyester mesh, as a synthetic
material, can be prone to infections, especially when used
in ischaemic limb with potentially infected tissue. Gener-
ally, infection rates after infrainguinal prosthetic bypasses
are reported to range from 1% to 6%.26,27
Results of this study indicate that the use of external
polyester scaffolding for varicose or dilated vein grafts is
safe. There was one infection which was not directly
related to the polyester mesh. Other adverse effects were
not observed in this series. Possible limitations of this
feasibility study are the lack of a control group and a rather
short follow-up time. The study population is also quite
heterogeneous due to some differences in indications for
polyester mesh use between participating centres.
In conclusion, polyester mesh is safe and feasible
adjunct to infrainguinal bypass using suboptimal autologous
vein grafts with no harmful effects observed in this study.
However, larger prospective series and longer follow-up
time will still be needed to prove its safety. In order to
prove a benefit with respect to incidence of vein graft
stenosis and graft patency, randomised controlled trials
comparing polyester scaffolded vein grafts with non-scaf-
folded ones and with prosthetic bypass material are obvi-
ously needed. External scaffolding may enable the use of
vein grafts of compromised quality.
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